PCP
ANAC

Perimeter Capital Partners’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Perimeter Capital Partners’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-14,870
Closed -$364K – 91
2014
Q3 		$364K Sell
14,870
-43,664
-75% -$887K 0.62% 22
2014
Q2 		$1.04M Buy
58,534
+25,311
+76% +$407K 0.53% 93
2014
Q1 		$665K Buy
+33,223
New +$644K 0.33% 124

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Perimeter Capital Partners's ANAC Position: Q4 2014 in Review

Perimeter Capital Partners sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2014, closing a stake of 14,870 shares — an estimated $364K sold.

Perimeter Capital Partners first reported a position in ANAC in Q1 2014 and held it in 3 quarters. The position peaked at $1.04M in Q2 2014. 147 funds tracked by Wall St. Rank hold ANAC as of Q4 2014.

  • Perimeter Capital Partners reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2014 after selling out during the quarter.
  • Perimeter Capital Partners sold 14,870 ANACOR PHARMACEUTICALS INC COM shares in Q4 2014, an estimated $364K.
  • Perimeter Capital Partners first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 3 quarters.
  • Perimeter Capital Partners's ANACOR PHARMACEUTICALS INC COM position peaked at $1.04M in Q2 2014.
  • 147 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2014.

Based on Perimeter Capital Partners's 13F filing for Q4 2014.